Outlook Therapeutics, Inc. - 8-K Filing
Outlook Therapeutics stockholders approved a common stock authorization increase to 600M shares and other proposals at its July 16 special meeting. (Items: 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year On July 16, 2026, at a special meeting of stockholders (the “Special, 5.07 Submission of Matters to a Vote of Security Holders At the Special Meeting, the Company’s stockholders voted on three proposals, which are de, 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit No)
Tickers: $OTLK